Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$629.2M
-4.2% from 2023
Prescriptions
256K
$2,461.15 per claim
Patients
29K
13,163 prescribers
Total spending, 2024
$629.4M
$21,551.13 per patient
Medicare prescription drug plans paid $629.2M for Tivicay in 2024, for 255,638 prescriptions and refills to 29,191 patients (down 4.2% from 2023). The average cost per claim was $2,461.15.
California had the highest Medicare cost for Tivicay in 2024: $78.2M for 28,188 claims, followed by Florida ($74.7M).
Sharon D Reiley, nurse practitioner in Jacksonville, FL, had the highest Medicare cost for Tivicay in 2024: 706 claims costing $1.7M.
Tivicay is made by GSK plc (GSK), listed in the Medicare spending data as Viiv Healthcare.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Sharon D Reiley Jacksonville, FL | Nurse Practitioner | 706 | 82 | $1.7M |
| Alexander R del Rosario Palm Springs, CA | Internal Medicine | 527 | 75 | $1.4M |
| Gennady Nosovitsky |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 13,140 | 281,703 | 31,520 | $650.3M |
| 2023 | 13,288 | 266,669 | 30,064 | $656.8M |
| 2024 | 13,163 | 255,638 | 29,191 | $629.2M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Physician Assistant |
| 479 |
| 48 |
| $1.3M |
| Cecilia D Aduako Georgetown, SC | Infectious Disease | 595 | 46 | $1.3M |
| Cyril R Gaultier Palm Springs, CA | Infectious Disease | 386 | 53 | $1.2M |
| Clayton O Barbour II Cathedral City, CA | Internal Medicine | 426 | 48 | $1.2M |
| Deborah L Holmes North Miami Beach, FL | Internal Medicine | 463 | 51 | $1.1M |
| Stephanie J Skipper Orlando, FL | Nurse Practitioner | 417 | 46 | $1.1M |
| Natalie N Vanek Houston, TX | Infectious Disease | 448 | 50 | $1.1M |
| Terry L Wilder Orlando, FL | Nurse Practitioner | 427 | 48 | $1.1M |
| Dong Phuong H Nguyen San Francisco, CA | Pharmacist | 145 | 48 | $1.1M |
| Jihad Slim Newark, NJ | Infectious Disease | 438 | 51 | $1.0M |
| Ann E Stapleton Palm Springs, CA | Internal Medicine | 382 | 45 | $987K |
| Akinwale O Olatosi Camden, SC | Internal Medicine | 403 | 39 | $976K |
| Molly Stenzel Portland, OR | Infectious Disease | 145 | 41 | $972K |
| Michael Robinson Riverside, CA | Family Practice | 363 | 43 | $969K |
| Michael P Mullen New York, NY | Infectious Disease | 346 | 36 | $969K |
| Lucy S Ung Loma Linda, CA | Pharmacist | 164 | 40 | $956K |
| Tracy M Carlson Albuquerque, NM | Internal Medicine | 395 | 44 | $949K |
| Joseph P McGowan Manhasset, NY | Infectious Disease | 366 | 39 | $903K |
| Audrey W Brown Columbus, GA | Internal Medicine | 416 | 49 | $899K |
| Ardis A Moe Los Angeles, CA | Family Practice | 323 | 36 | $881K |
| Marc A Johnson Charlotte, NC | Internal Medicine | 379 | 50 | $877K |
| Stephen A Renae Fort Lauderdale, FL | Infectious Disease | 411 | 59 | $869K |
| Delia E Bullock San Antonio, TX | Internal Medicine | 357 | 46 | $869K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Viiv Healthcare GSK | 255,731 | $629.4M |